Use access key #2 to skip to page content.
$26.54 2.61 (10.92%)
10/13/2008 4:00 PM

Immucor, Inc. (BLUD)

CAPS Rating:
****

The Company develops, manufactures and sells a complete line of reagents and automated systems used by hospitals, clinical laboratories and blood banks in tests performed to detect and identify certain properties of human blood.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BLUD

Add Stock to Watchlist

What the Community Thinks

Total Members

344 Outperforms
13 Underperforms
 

All-Stars

109 Outperforms
0 Underperforms
 

Wall Street

3 Outperforms
0 Underperforms
 

Members bullish on BLUD are also bullish on:

Members bearish on BLUD are also bearish on:

Ticker Tags

Small Cap (1922), Diagnostic Substances (53)
Suggest a tag

Immucor, Inc. At A Glance

Current Price: $26.54
Last Trade Time: 10/13/2008 4:00 PM
Open: $24.82
Previous Close: $23.93
Daily Range: $24.65 - $26.62
52-Week Range: $17.30 - $38.74
Volume: 648,436
Market Cap: $2.18B
P/E Ratio: 30.41
Compare Our Special Broker Offers!

Stock Trends

BLUD VS S&P 500 (SPY)

BLUD 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for BLUD

More Headlines...

Top Bull Pitch

Recs

3

Immucor, Inc. (BLUD)

Avatar TrackZacks (84.25) Submitted: 1/17/08 5:14 PM

Target $40 for BLUD

Posted Thu Jan 17, 05:08 pm ET
by Tom Park

Blood-testing product developer Immucor, Inc. (BLUD) has recently been upgraded to a Buy as a pull-back in the stock helped its valuation become more attractive. Zacks senior medical devices industry analyst Tom Park had these comm...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Immucor, Inc. (BLUD)

Avatar morgan628 (< 20) Submitted: 10/05/07 5:07 PM

Unless the company does something extraordinary I do not see much upside to this stock. Admitedly Immucor is a leader in the area of blood testing, there is a contract in place with the American Red Cross for 19 Galileo units which will add about $5 million per year in revenue once the units are ac...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 52 :   1 2 3 4 5 Next » Jump to page:

Show Pitch Replies

Recs

0

 (BLUD)

Avatar SwordAgain (< 20) Submitted: 9/25/08 8:38 PM : Underperform Start Price: $30.54 BLUD Score: -11.21

10/2/08, 8:30 AM Overpriced on this run-up. Will begin to see erosion from competitor products that use alternative diagnositic techniques including other fluids than blood. Point-of-care products that will be lower cost and have lower margins.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BLUD)

Avatar pilotg2 (42.18) Submitted: 7/17/08 2:32 PM : Outperform Start Price: $28.73 BLUD Score: 20.81

A few days late on this one, but all indicators are still showing a very strong buy. Price is above my preferred buy price, but still just under the 25% mark of my target price of 39.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BLUD)

Avatar JohnnyiPhone (< 20) Submitted: 6/12/08 2:37 PM : Outperform Start Price: $26.56 BLUD Score: 33.01

Company


Return, 1998-2007


Jan. 1, 1998 Market Cap





Hansen Natural (Nasdaq: HANS)


21,201%


$16.5 million





Asta Funding


8,252%


$3.1 million





Celgene (Nasdaq: CELG)


6,771%


$129.0 million





Apple (Nasdaq: AAPL)


5,959%


$1.7 billion





Comtech Telecommunications (Nasdaq: CMTL)


4,246%


$11.3 million





Daktronics


3,493%


$23.1 million





Green Mountain Coffee Roasters (Nasdaq: GMCR)


3,455%


$24.7 million





Clean Harbors


3,378%


$15.8 million





Innodata Isogen


3,135%


$3.1 million





Immucor


2,941%


$70.0 million





Data from Capital IQ, a division of Standard & Poor's. Includes only U.S. stocks listed with verifiable stock price histories on major exchanges.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BLUD)

Avatar NoTouch5Yr (96.05) Submitted: 5/22/08 4:00 PM : Outperform Start Price: $25.53 BLUD Score: 39.23

As with all my picks: A very attractive P/E, excellent EPS growth rate and high five year growth prospects.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BLUD)

Avatar jatava (26.00) Submitted: 5/21/08 10:33 PM : Outperform Start Price: $25.40 BLUD Score: 39.94

10.000

Report this Post Replies: 1 | Reply | Permalink

Results 1 - 5 of 52 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 3 of 3  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackSusquehanna 68.85 03/19/08 Outperform NS $21.98+20.75%-32.94%+53.69
TrackZacks 84.25 01/17/08 Outperform 3M $30.52-13.04%-32.59%+19.55 Toggle the visibility of 60-Second Pitch and replies
TrackRonBaron 96.46 09/30/07 Outperform NS $35.75-25.76%-41.05%+15.29 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer 77.11 05/23/06 Outperform 3W $17.29+53.50%-28.97%+82.46

Results 1 - 3 of 3  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners